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Abstract
Background:  Chronic hypoxia in utero (CHU) is one of the most common insults to fetal
development and may be associated with poor cardiac recovery from ischaemia-reperfusion injury,
yet the effects on normal cardiac mechanical performance are poorly understood.
Methods: Pregnant female wistar rats were exposed to hypoxia (12% oxygen, balance nitrogen)
for days 10–20 of pregnancy. Pups were born into normal room air and weaned normally. At 10
weeks of age, hearts were excised under anaesthesia and underwent retrograde 'Langendorff'
perfusion. Mechanical performance was measured at constant filling pressure (100 cm H2O) with
intraventricular balloon. Left ventricular free wall was dissected away and capillary density
estimated following alkaline phosphatase staining. Expression of SERCA2a and Nitric Oxide
Synthases (NOS) proteins were estimated by immunoblotting.
Results: CHU significantly increased body mass (P < 0.001) compared with age-matched control
rats but was without effect on relative cardiac mass. For incremental increases in left ventricular
balloon volume, diastolic pressure was preserved. However, systolic pressure was significantly
greater following CHU for balloon volume = 50 μl (P < 0.01) and up to 200 μl (P < 0.05). For higher
balloon volumes systolic pressure was not significantly different from control. Developed pressures
were correspondingly increased relative to controls for balloon volumes up to 250 μl (P < 0.05).
Left ventricular free wall capillary density was significantly decreased in both epicardium (18%; P <
0.05) and endocardium (11%; P < 0.05) despite preserved coronary flow. Western blot analysis
revealed no change to the expression of SERCA2a or nNOS but immuno-detectable eNOS protein
was significantly decreased (P < 0.001) in cardiac tissue following chronic hypoxia in utero.
Conclusion:  These data offer potential mechanisms for poor recovery following ischaemia,
including decreased coronary flow reserve and impaired angiogenesis with subsequent detrimental
effects of post-natal cardiac performance.
Background
Prenatal hypoxia may be one of the most common insults
to the fetus during pregnancy. Exposures can vary from
acute short-term insults [1] to chronic exposures (chronic
hypoxia in utero – CHU) and have different impacts on
fetal development. The impact of CHU on the heart and
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cardiac performance is unclear. The heart develops early
during organogenesis and is functional at day 10 of gesta-
tion [2]. This coincides with the transition from a meta-
bolic dependence upon glycolysis for ATP production
(hence the absence of oxygen) and the transition to
dependence on oxidative metabolism [3] and cardiac
muscle fibre cross-sectional area showed a 5-fold increase
between days 10–19 of embryo development in the rat
[4]. This is indicative of significant hypertrophy resulting
from the increased workload, and may be an indirect
result of increased oxygenation. These changes indicate
that the rat fetus may be relatively resistant to oxygen dep-
rivation prior to this 10-day limit [5]. This is supported
through studies of the Hypoxia-Inducible Factor (HIF-
1α)-null mouse showing growth retardation at day 9 of
development and death at day 10.5 [6], the abnormalities
occurring in heart and blood vessels. Ultrasound studies
of the human fetus reveal changes to regional blood flow
during CHU [7], and dilatation of coronary vessels in
growth-restricted human fetus [8].
CHU in lambs (initiated by high-altitude hypoxia) was
without affect on capillary density, Capillary:Fibre (C:F)
ratio and capillary volume density, but capillary diameter
significantly increased [9]. Similar observations were
noted following 20 days fetal anaemia in lambs (from day
115 gestation). However, in response to hypoxia a signif-
icant increase in rate of change of pressure development
in myocardium (dP/dt max) was recorded [10], however
this was not accompanied by changes to LV vessel number
or size [10] but was compensated for by augmented coro-
nary conductance measurements [11]. CHU in rats (12%
oxygen – day 15–21 gestation) led to decreased recovery
from ischemia-reperfusion injury in hearts following 25
min global ischaemia [12,13]. This was characterised by
increased Caspase 3 activation and apoptosis [12].
Increases in left ventricle/body mass ratio and increased
collagen I and III were also noted for CHU rats [13] sug-
gesting adaptive cardiac remodelling.
For adult rats exposed to chronic hypoxia expression of
endothelial Nitric Oxide Synthase (eNOS) was noted to
increase at both mRNA and protein levels [14], however
controversy remains over the impact of CHU on the
expression of endothelial nitric oxide synthase (eNOS) in
the developing fetus. No changes to eNOS expression in
rat cardiac tissue were noted following CHU (12% oxygen
– day 15–21 gestation) [13] however others report the
absence of eNOS in cardiac tissue following CHU for days
15–21 of pregnancy [12] without compensatory increased
expression of either iNOS or nNOS. By contrast, fetal
hypoxia in near term guinea-pigs for 14 days between
days 46–60 (term = 65 days) revealed preserved sensitivity
to exogenous NO donors and an increase in eNOS mRNA
expression [15]. More detailed analysis revealed preserved
eNOS mRNA in coronary vessels, but decreased eNOS
mRNA and protein in cardiomyocytes [16]. This may
highlight important species differences in regulation of
coronary flow, namely the importance of NO in the pres-
ervation of flow for the guinea pig [17-19] compared with
the relative insensitivity of rat coronary flow to NOS inhi-
bition [20,21]. Before investigating the impact of CHU on
eNOS in the rat we must detail potential changes to car-
diac work and factors that may influence coronary flow,
including capillary density.
We hypothesise that exposure to CHU during this critical
period when oxygen use increases (Day 10–20 of preg-
nancy) will increase neonatal cardiac work following cat-
echolamine release and increasing coronary perfusion.
The resulting high flow hypoxia will increase conductance
and will reduce stretch-mediated angiogenic stimuli (as a
result of shortened diastolic period) [22] resulting in
decreased left ventricular capillary density.
Using the langendorff-perfused rat heart we will quantify
the mechanical performance and measure basal coronary
flow for adult rats subjected to CHU. In addition, we will
estimate the protein expression of both calcium-handling
proteins and the nitric oxide synthases to characterise the
myocardium produced following exposure to CHU.
Methods
Materials
Oxygen-free nitrogen gas was obtained from British Oxy-
gen Corporation (BOC, UK). Buffer reagents and nitro-
blue tetrazolium reagent for determining capillary density
were obtained from Sigma (Sigma Ltd, Poole, UK) and
were of analytical grade or better. Massons Trichrome
Stain to quantify tissue collagen was purchased from R.A.
Lamb Ltd (Eastbourne, East Sussex, UK). Ventricular bal-
loons were constructed 'in house' using Saran Wrap poly-
thene film.
Animals
Animals were maintained in accordance with the UK
Home Office, Animal Scientific Procedures Act (1986)
and housed at 22°C 12 hr light/12 hr dark with ad libitum
access to food and water. After confirmation of mating,
female Wistar rats (200 gm – Charles River, UK) were then
housed singly in a hypoxic chamber and breathing room
air. 10 days following mating the animals were exposed to
a normobaric hypoxic atmosphere (12% oxygen, balance
nitrogen) for 10 days. During this time the enclosed
atmosphere was circulated through silica gel and soda
lime to trap both water vapour and carbon dioxide. At 20
days post-mating the animals were transferred to room air
and the pregnancy progressed as normal.BMC Cardiovascular Disorders 2009, 9:1 http://www.biomedcentral.com/1471-2261/9/1
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At birth, pups remained with the mother and were
weaned normally. Following weaning at 4 weeks of age,
the animals were divided by sex and the males housed
with litter mates in groups (n = 5). These litters were then
maintained for a further 10 weeks in normal room air
with ad libitum access to both food and water.
Surgical preparation
All experiments were carried out on male rats (mean age
11 weeks). Animals were prepared for surgery as outlined
previously [23]. Briefly, animals were anaesthetised using
halothane by inhalation (3.5% v/v in oxygen). The tra-
chea was exposed and cannulated with a rigid tube for
attachment of the spirometer (AD Instruments, Charl-
grove, Oxfordshire, UK). Right femoral artery was cannu-
lated for the estimation of arterial blood pressure and
collection of blood samples. Patency of all cannulae was
maintained by periodic flushing with phosphate-buffered
saline containing bovine albumin (2% w/v) and triso-
dium citrate (20 mM final concentration). Arterial blood
pressure was measured through a plastic catheter and con-
nected to a pressure transducer (MEMSCAP, Skoppum,
Norway). Heart rate and developed pressure were derived
from this pressure recording.
Tissue isolation and heart perfusion
Animals were prepared surgically as outlined previously
[24]. Briefly, anaesthesia was induced with pentobarbital
(60 mg/kg ip in saline) and following thoracotomy hearts
excised with lungs and thymus in situ and immersed in
ice-cold Krebs-Hensleit medium. Excess tissue was dis-
sected away, the thymus divided to reveal the aortic arch
and the aorta was trimmed at the level of the carotid artery
branches and cannulated (16 G needle). Hearts were per-
fused in retrograde fashion as outlined previously
[12,13,24]. Flow through the heart was established and
extra tissue was dissected away. An incision was made in
the right ventricle and the left atrial appendage removed.
A small flexible non-elastic balloon was inserted into the
left atrium through the mitral valve and into the left ven-
tricle. This fluid-filled balloon was attached to a fine plas-
tic catheter and connected to a pressure transducer
(MEMSCAP, Skoppum, Norway) and a graduated syringe
(0–1000 μl: Hamilton, Nevada, USA). Hearts were main-
tained at 37°C and perfused at a constant pressure (100
cm H2O) with a Krebs-Hensleit crystalloid medium sup-
plemented with glucose (10 mM) and CaCl2 (1.3 mM)
gassed with oxygen/CO2 (95:5). Developed pressure was
measured following isovolumic contraction of the fluid-
filled balloon and recorded to computer using a digital
interface (AD Instruments, Chalgrove, Oxford, UK).
Ventricular Performance
Ventricular performance was estimated as outlined previ-
ously [24]. Briefly, the initial balloon volume was
adjusted until the diastolic pressure recorded measured 0
mmHg and the developed pressure (difference between
systolic and diastolic pressures) was <10 mmHg. This was
referred to as a balloon volume of Zero. Balloon volume
was increased in incremental steps (50 μl) and developed
pressure was recorded in real time. Pressures were allowed
to stabilise until diastolic pressure remained constant
before initiating further increases in balloon volume.
Incremental increases in balloon volume were performed
until the peak systolic pressure developed exceeded 200
mmHg. The balloon was then deflated and the process
repeated. Coronary flow was estimated from timed collec-
tions of a known volume of perfusate and expressed as
volume/unit time/unit mass of cardiac tissue. Typically, 3
ml of coronary effluent was collected with collection time
measured and subsequently expressed relative to cardiac
mass.
Ventricular performance was calculated off-line following
the experiment using computer analysis software (Chart
Version 5.0, AD Instruments, Chalgrove, Oxford, UK).
Heart rate, systolic pressure, diastolic pressure and hence
developed pressure were measured. Rate of change of
pressure (+dP/dt) was calculated from the maxima of first
order derivative of pressure trace. Rate pressure product
(RPP) was calculated at each balloon volume as the prod-
uct of heart rate (bpm) × developed pressure (mmHg).
Capillary Density
Tissues were blotted dry and weighed. The atria and con-
nective tissue were dissected away and discarded. A trans-
verse midline incision across the left ventricle was made.
The lower portion (apex) of the heart was taken and the
left ventricular free wall dissected away and mounted onto
cork disks (22 mm: R.A. Lamb, Eastbourne, East Sussex,
UK) in Tissue-Tek OCT compound (Sakura, Torrance, CA)
before freezing in liquid nitrogen-cooled isopentane. For
selected hearts whole myocardium was snap frozen in liq-
uid nitrogen for Western blotting. Cryostat sections (10
μm) were cut and fixed onto glass slides. Capillaries were
visualised using an alkaline phosphatase method [25]
using nitro-blue tetrazolium reagent generating an insolu-
ble formazan pigment. Capillary density was quantified
from digital images (magnification ×200) by estimating
capillary number in transverse-sectioned regions of LV
free wall of known area. Three fields of epicardium and
endocardium from six non-consecutive sections (mini-
mum separation 50 μm between sections) were counted.
Care was taken to estimate capillary numbers in different
regions of LV free wall for separate sections. Sections of
endocardium and epicardium were counted at random
and the viewer was blinded to the origins of the tissue.
Data is expressed as capillary number/mm2  cross-sec-
tional area of LV myocardium. Selected tissue sectionsBMC Cardiovascular Disorders 2009, 9:1 http://www.biomedcentral.com/1471-2261/9/1
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were stained with Masson's Trichrome to quantify colla-
gen infiltration and fibrosis.
Diffusion distance
Diffusion distance was calculated using the estimations of
capillary density using the following equation R =
1000√Nπ where N is the number of capillaries/mm2. This
value is equal to the mean half distance between two cap-
illaries in cross section and represents an index of average
capillary supply [26].
Immunoblotting for proteins
Western blot analysis was carried out on frozen whole
heart tissue following removal of adipose tissue and atria.
Standard Western immunoblotting techniques were used
for the detection and estimation of relative amounts of
SERCA2, eNOS, iNOS and nNOS (20–80 μg protein).
Briefly, cardiac tissue (50 mg) was powdered in liquid
nitrogen and extracted with RIPA buffer containing pro-
tease inhibitors, before centrifugation (10,000 rpm for 10
min) and recovery of the supernatant. The PVDF-mem-
branes were probed with antibodies specific for SERCA2
(Santa Cruz – dilution 1:1000), mouse monoclonal anti-
eNOS (1–500 dilution), mouse monoclonal anti-iNOS
(1–500 dilution), mouse monoclonal anti-nNOS (1–
1000 dilution) (Becton Dickinson, Oxford, UK). Appro-
priate HRP-linked secondary antibodies were used and
membranes developed using enhanced chemilumines-
ence (ECL) detection (Roche). Densitometry of Western
blots was estimated using ImageJ software (NIH). Protein
expression was corrected for the expression of an internal
control (tubulin).
Statistical analysis
Statistical analysis was carried out using Single Factor
ANOVA analysis with Bonferroni correction for multiple
comparisons where appropriate. Data represents mean ±
standard deviation.
Results
Prenatal hypoxia did not alter pregnancy rate or the num-
bers of pups born. Pregnancies were of normal duration
and the pups born alive. Mean litter size for CHU rats was
9 pups (range 2–15) and for control rats mean litter size
was 11 pups (range 2–16). Body mass of the pups at birth
was not measured to avoid disturbing the mothers. Body
mass estimates at weaning revealed that CHU rats were
significantly heavier than controls (68 ± 5 gm control vs
86 ± 8 gm CHU: P < 0.01).
Post-mortem measurements
At post-mortem, body mass of CHU rats was significantly
greater than age-matched controls (P < 0.001: Figure 1A).
Absolute gonadal fat mass was significantly increased in
CHU rats (2.25 ± 0.25 gm control vs 8.37 ± 1.07 gm CHU;
P < 0.001). Estimation of tissue mass as percentage of
body mass revealed that gonadal white adipose tissue
(WAT) increased ~2-fold in the CHU rats compared with
controls (P < 0.001; Figure 1B) whereas Adrenal mass for
the CHU rats decreased ~30% compared with controls (P
< 0.001; Figure 1B), although no differences were seen in
absolute adrenal mass (65 ± 9 mg control vs 70 ± 5 mg
CHU). Absolute cardiac mass for CHU rats was signifi-
cantly greater than for controls (0.97 ± 0.1 gm control vs
1.33 ± 0.07 gm CHU; P < 0.001) however, relative heart
mass in CHU rats was not significantly different from con-
trol rats (Figure 1B).
Direct measurement of in vivo mean arterial blood pres-
sure (MAP) revealed a 10% increase in MAP for anaesthe-
tised CHU rats when compared with control, however this
did not reach statistical significance (Table 1): in addition,
heart rate was unchanged between control and CHU rats.
Ex vivo heart rate was measured when stable perfusion was
established, and no difference was noted between hearts
from control and CHU rats (table 1). End-diastolic vol-
ume (calculated from the linear regression of diastolic
performance curve for values greater than zero at the point
the regression line bisected the balloon volume at diasto-
lic pressure = Zero) was increased by 4% in CHU rats (292
± 45 μl control vs 305 ± 32 μl CHU), (NS: Table 1).
Ex vivo cardiac performance
With increasing ventricular balloon volume the peak
systolic pressure increased for control animals (Figure
2A). For CHU rats peak systolic pressure reached an initial
peak of 125 mmHg at balloon volume of 50 μl (P < 0.01)
and the developed pressure then remained at this plateau
value (~125 mmHg) with increasing balloon volume up
to balloon volume = 400 μl. Peak systolic pressure meas-
ured for CHU rats was significantly greater than control
for increasing balloon volumes up to 200 μl (P < 0.05) at
which point the peak systolic pressure followed the same
pattern as control rats (Figure 2A). Measured diastolic
pressure was not significantly different between control
and CHU rats with increasing balloon volume (figure 2B).
LV developed pressure per unit cardiac mass increased
with increasing balloon volume for control rats, reaching
a peak of 100 mmHg at balloon volume = 250 μl. For
CHU rats developed pressure peaked at 120 mmHg at bal-
loon volume = 50 μl, 2-fold higher than that recorded for
controls at an equivalent balloon volume (P < 0.001)
(Figure 2C). The developed pressure remained constant
up to 250 μl balloon volume (P < 0.05, compared with
control) and continued to decline in a pattern similar to
control rats (Figure 2C) with subsequent increases in bal-
loon volume. For balloon volumes >250 μl, developed
pressures generated for CHU heart LV were not signifi-
cantly different from control hearts.BMC Cardiovascular Disorders 2009, 9:1 http://www.biomedcentral.com/1471-2261/9/1
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Body and tissue mass at post-mortem Figure 1
Body and tissue mass at post-mortem. Data represents body (A) and relative tissue masses (B) for control and adult off-
spring from pregnant female rats exposed to prenatal hypoxia. Tissue masses represented as a percentage of body mass to 
normalise for differences in body mass between control and CHU rats. Data represents Mean ± standard deviation (n = 6 for 
both control and CHU rats). Statistical comparisons represent: *** P < 0.001.
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Rate of pressure development (measured as +dP/dt)
reached a maximum in control rats at balloon volume =
250 μl and subsequently declined (figure 3A). For CHU
rats dP/dt reached a peak at 50 μl and was sustained until
balloon volume = 200 μl, declining thereafter in a pattern
corresponding to that of control rats (Figure 3A). Rate of
ventricular relaxation (measured as -dP/dt) was decreased
at all points when compared with control hearts (figure
3B) reaching statistical significance at balloon volumes
>50 μl (P < 0.01). Maximum -dP/dt was achieved at low
balloon volume (100 μl) for controls and rate decreased
with increasing balloon volume (figure 3B). Rate-pressure
product (RPP) expressed per unit cardiac mass followed a
similar pattern to dP/dt in control rats, peaking at balloon
volume = 250 μl (Figure 3C), whereas for CHU rats RPP
reached a maxima at balloon volume = 50 μl, (P < 0.01;
Figure 3C). RPP was maintained at this peak value for
increasing balloon volumes up to a maximum of 200 μl
for CHU rats (P < 0.01 vs control). For further increases in
balloon volume RPP declined in a similar pattern to con-
trols (Figure 3C).
Coronary flow and capillary density
Coronary flow decreased with increasing balloon volume
similarly for control rats and CHU rats (NS; Figure 4A).
There was a 7% decrease in capillary density between epi-
cardium and endocardium for control rats, (NS; Figure
4B). A 19% lower capillary density (P < 0.05) was
recorded for epicardium in CHU rats when compared
with control rats, with endocardium showing an 11%
lower capillary density (P < 0.05) (Figure 4B). The calcu-
lated oxygen diffusion distance for epicardium and endo-
cardium was significantly increased in CHU rats (P < 0.05
for both; Figure 4C). Estimation of percentage volume
density of collagen recorded no difference in collagen
infiltration between control and CHU hearts (data not
shown).
Western blot analysis
Densitometric analysis of Western blot for cardiac tissue
revealed a significant decrease in protein corresponding to
eNOS for the CHU hearts detectable in the linear range for
control samples (Figure 5; P < 0.001). This was verified by
both molecular mass and the use of appropriate positive
controls (data not shown). Increasing exposure time for
autoradiograms revealed that eNOS protein was present at
very low levels in CHU rats, however this was beyond the
linear range for densitometric estimation. Levels of pro-
tein expression for SERCA2 estimated by Western blot
were not significantly different for CHU hearts (Figure 6;
NS). Levels of protein expression for nNOS were also esti-
mated by Western blot and shown not to be significantly
different for CHU hearts (Figure 6; NS). Investigation of
iNOS expression revealed this protein was undetectable in
control and CHU myocardium (data not shown).
Discussion
The impact of in utero exposure to adverse environmental
factors on the development of the fetus is not in doubt,
however how these alterations affect myocardium in par-
ticular is currently unclear. These experiments represent
one of the first detailed investigations of the mechanical
performance of the ex vivo perfused heart and demonstrate
increased contractile performance coupled with impaired
relaxation of the heart, in the absence of sympathetic
innervation and hormonal inputs. In addition, we dem-
onstrate for the first time that CHU during this critical
period of embryonic cardiac development may signifi-
cantly decrease capillary density for epicardium and endo-
cardium in the adult heart, with possible implications for
maintenance of coronary perfusion and cardiac allometric
growth.
The increase in body mass for CHU rats is striking, ini-
tially observed at weaning and is manifest largely through
increased adipose tissue mass. The 2.5-fold increase in rel-
ative gonadal WAT mass was similarly distributed in other
adipose tissue beds (data not shown), including peri-renal
depots, and may reflect a profound metabolic distur-
bance. Coupled with the apparent decrease in adrenal
mass, the CHU rats express a phenotype similar to exces-
sive glucocorticoid treatment [27]. The origins of this are
unclear at present, yet enhanced adipose tissue mass cou-
pled with ectopic secretion of glucocorticoid by adipose
tissue may result in the adrenal atrophy reported. Consist-
ent with this, CHU in sheep led to increased adipose
Table 1: Blood pressure and heart rate under anaesthesia and at post-mortem for control rats and adult offspring from pregnant 
female rats exposed to hypoxia during pregnancy.
Measurement Number Control Prenatally Hypoxic Statistical Comparison
In vivo Heart Rate (beats.min-1) 5 405 ± 60 397 ± 55 NS
Mean arterial blood pressure (mmHg) 5 115 ± 15 126 ± 15 NS
In vitro Heart Rate (beats.min-1) 10 277 ± 33 251.8 ± 24.3 NS
Estimated End Diastolic Volume (μl) 10 292.1 ± 44.7 304.9 ± 32.0 NS
Data represents Mean ± SD for control and CHU rats. Statistical comparisons are using a single factor ANOVA with statistical significance set at P 
< 0.05.BMC Cardiovascular Disorders 2009, 9:1 http://www.biomedcentral.com/1471-2261/9/1
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Cardiac performance Figure 2
Cardiac performance. Data represents measurements taken from Langendorff-perfused hearts for control rats and adult 
offspring from pregnant female rats exposed to prenatal hypoxia (A) Peak systolic pressure (B) Diastolic pressure (C) Devel-
oped pressure. Data represents Mean ± standard deviation (n = 10 hearts). Statistical comparisons represent: * P < 0.05; ** P 
< 0.01; ***P < 0.001.
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Cardiac contractility and cardiac work Figure 3
Cardiac contractility and cardiac work. (A). Peak +dP/dt (B) Peak -dP/dt (C). Rate-pressure product Data represents 
Mean ± standard deviation (n = 10 hearts). Statistical comparisons represent: * P < 0.05; ** P < 0.01.
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Coronary flow, capillary density and oxygen diffusion Figure 4
Coronary flow, capillary density and oxygen diffusion. (A) Coronary flow was measured as timed recovery of a known 
volume of perfusate from coronary drainage. Data represents Mean ± standard deviation (n = 10 hearts). (B) Capillary density. 
(C) Oxygen diffusion distance. Data represents Mean ± standard deviation (n = 5 hearts). Statistical comparisons represent: * P 
< 0.05.
0
2
4
6
8
10
12
14
16
Epicardium Endocardium
D
i
f
f
u
s
i
o
n
 
D
i
s
t
a
n
c
e
 
(
m
)
Control Chronic Hypoxia
**
C
a
p
i
l
l
a
r
y
 
D
e
n
s
i
t
y
 
(
c
a
p
i
l
l
a
r
i
e
s
/
m
m
2
)
0
500
1000
1500
2000
2500
Epicardium Endocardium
Control Chronic Hypoxia
* *
(n=5) B
C (n=5)
0
1
2
3
4
5
6
7
8
9
0 50 100 150 200 250 300 350 400 450 500
Balloon volume ( l)
C
o
r
o
n
a
r
y
 
F
l
o
w
 
(
m
l
/
m
i
n
/
g
m
)
Control CHU
A (n=10)BMC Cardiovascular Disorders 2009, 9:1 http://www.biomedcentral.com/1471-2261/9/1
Page 10 of 14
(page number not for citation purposes)
Protein expression for eNOS and tubulin in whole heart Figure 5
Protein expression for eNOS and tubulin in whole heart. Representative autoradiogram taken from control and CHU 
hearts. Estimation of relative abundance of eNOS and SERCA2 by densitometry. Data represents Mean ± standard deviation of 
relative expression corrected for tubulin (n = 6 hearts). Statistical comparisons represent: *** P < 0.001. Quantiation made on 
T = 30 sec autoradiogram to ensure linearity of response for control samples. T = 300 sec autoradiogram included to show 
presence of eNOS protein at low levels for CHU samples.
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Protein expression for SERCA2, nNOS and tubulin in whole heart Figure 6
Protein expression for SERCA2, nNOS and tubulin in whole heart. Figure represents autoradiogram taken from con-
trol and CHU hearts. Data represents mean ± standard deviation for relative densitometric estimates (n = 6 hearts). Statistical 
significance set at P < 0.05.
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expression of 11β-hydroxysteroid dehydrogenase-1
enzyme (11β-HSD1), responsible for the tissue-specific
recycling of glucocorticoid [28]. Our hypothesis of cardiac
hypertrophy following CHU, and previously noted for LV
in rats exposed to CHU (days 15–21 of pregnancy [16]) is
not proven, however we cannot dismiss the potential in
later life. The relative obesity noted may be predisposing
factor for cardiac hypertrophy occurring at later stages
although none was evident at this young age (9–11
weeks), and is further supported by the preservation of
estimated end diastolic volume.
Cardiac performance
The enhanced cardiac performance for CHU rats observed
during early increases in balloon volume (an index of the
response to increased preload) may be an early adaptation
in contractility to overcome the apparent obesity. How-
ever, previous estimates of ventricular volume in rats for
this age/cardiac mass [29] suggest that cardiac perform-
ance is not significantly different from control when ani-
mals are at rest (ventricular volume ~250 μl) and hence
the early augmentation in developed pressure (represent-
ing volumes of low ventricular filling) with apparently
normal cardiac mass may have unrelated origins. To date,
we have found no other example of this early increased
cardiac performance coupled with preservation of normal
performance at higher balloon volumes (higher cardiac
work). Overexpression of genes coding for calcium trans-
porters has previously shown to augment contractile per-
formance, including oxerexpression of sarcoplasmic-
endoplasmic reticulum Ca2+ ATPase 2 (SERCA2) [30-32],
yet overexpression increased cardiac performance at all
workloads, rather than over the narrow range recorded
here. Normal expression of SERCA2 was confirmed in
these hearts, so alternate mechanisms may have been
recruited, including alteration to myosin heavy chain sub-
type expression.
Impaired relaxation (lusitrophy) has been previously
noted for CHU rat hearts, characterised by decreased -dP/
dt and increased LVEDP [16] and may be indicative of
early fibrosis. This was undetectable using the Masson's
Trichrome staining technique used here, however other
groups exploiting electron microscopy revealed develop-
ment of fibrosis at 4 months following CHU [16]. This
may represent a methodological discrepancy with Mas-
son's Trichrome being better suited to detection of focal
fibrosis rather than diffuse filamentous fibrosis. Previous
studies document the influence of nitric oxide on diastolic
performance (reviewed [33]) and, notably, in ventricular
relaxation in the isolated perfused heart [34]. We cannot
rule out the involvement of NO production in the impair-
ment of lusitrophy and the decrease in immuno-detecta-
ble eNOS protein may contribute to the impaired
production of NO and retard cardiac relaxation in the
intact heart [35].
Capillary density
Early observations suggest that crystalloid-perfused hearts
show only ~60% perfusion of the available capillaries for
a single-pass [36]. This might imply that substantial
decreases in capillary density are possible before impair-
ment of mechanical performance is noted. The decreased
capillary density for both epicardium and endocardium
for CHU rats is surprising given the preserved cardiac per-
formance and coronary flow, suggesting that oxygenation
of the tissue was adequate [37,38]. No measure of arteri-
olar diameter was possible and dilation is the most likely
explanation for preserved coronary flow by means of
reduced vascular resistance. Interestingly, these observa-
tions raise the possibility of decreased coronary flow
reserve in the CHU rat [39], a characteristic previously
observed for examples of cardiac hypertrophy [40].
Indeed, over the entire range of balloon volumes studied
we show preserved cardiac mechanical performance and
coronary flow, implying that significant 'pathological'
impairment of coronary flow is necessary to exceed the
remaining coronary flow reserve.
Given the preserved coronary flow and sensitive, local
control of blood flow to match oxygen delivery with con-
sumption the pathways governing arteriolar dilation,
including nitric oxide, may be accentuated. An increase in
expression of endothelial nitric oxide synthase (eNOS) as
a consequence of decreased capillary density was antici-
pated given the primary role that endothelial NO release
plays in response to increased flow-mediated shear [41]
and its induction in response to chronic tissue hypoxia
[42]. However, direct measurement by Western blot
revealed a decrease in total eNOS protein for CHU hearts,
confirming previous observations, but over a different
window of hypoxia [12]. Inducible nitric oxide synthase
(iNOS) is not normally expressed in the adult heart
[43,44] but is induced following ischaemia-reperfusion
injury [45] and cardiac failure [46] and was not present at
levels detectable by Western blot in the CHU heart. Com-
pensatory expression of nNOS was previously recorded
for eNOS-/- mice [47] with specific inhibition of nNOS
revealing that flow-induced dilation of coronary vessels
was largely controlled by nNOS [48]. However, no com-
pensatory expression of nNOS was noted for CHU rats.
Other mechanisms by which the endothelium influences
arteriole dilation cannot be ruled out including KATP chan-
nels and the prostanoids.
The origins of decreased capillary density for CHU hearts
may result following allometric growth [49] of a gesta-
tionally small heart [15,50]. Indeed, for control rats capil-
lary density is highest at 1 month of age and fallsBMC Cardiovascular Disorders 2009, 9:1 http://www.biomedcentral.com/1471-2261/9/1
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continually following hypertrophy of the heart as a result
of normal growth [51], coupled with increases in myocyte
cross-sectional area [52]. Rapid growth in early life may
produce a heart of normal mass with relatively fewer car-
diomyocytes of larger size [53-55], and poor distribution
of capillaries [52].
Conclusion
We demonstrate that CHU led to enhanced developed
pressure and contractility in the isolated perfused heart.
Furthermore, we show that this altered performance does
not result from changes to SERCA2a protein directly but
may result form changes to other Ca2+ pathways. The
accompanying decreases in both epicardial and endocar-
dial capillary density may reflect changes to the mecha-
nisms controlling angiogenesis, imposed by the early
oxygen deprivation or enhanced allometric growth of a
gestationally small heart. In addition, the decreased capil-
lary supply to the myocardium may have consequences
for the development of cardiac hypertrophy in adulthood.
Abbreviations
CHU: Chronic Hypoxia in utero; SERCA2a: sarcoplasmic-
endoplasmic reticulum Ca2+ ATPase 2a; NOS: nitric oxide
synthase; WAT: white adipose tissue; ANOVA: analysis of
variance; RPP: rate-pressure product.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
DH designed the studies, undertook the capillary density
measurements and undertook the immunoblot analysis.
DH also drafted the manuscript and carried out the data
analysis and statistical analysis. VO undertook all of the
perfusion studies and collected tissue samples. All authors
read and approved the final manuscript
Acknowledgements
The authors wish to acknowledge the generous assistance of the Medical 
School, University of Birmingham (DH) for financially supporting this work. 
In addition, the authors wish to acknowledge the generous donation of tis-
sue by Dr. AM Coney and Prof. JM Marshall (Department of Physiology, 
School of Clinical and Experimental Medicine, University of Birmingham).
References
1. Powell SR, Mantell LL, Garramone V, Drexler S, Teichberg S: Acute
effects of nonlethal in utero hypoxia on fetal guinea pig heart
and lack of persistent cardiac or cerebral effects in the
neonate.  Biol Neonate 2004, 86(4):240-246.
2. Shepard TH, Muffley LA, Smith TH: Ultrastructural study of mito-
chondria and their cristae in embryonic rats and primates
(N. nemestrina).  Anat Rec 1998, 252(3):382-392.
3. Ellington SKL: In vitro analysis of glucose metabolism and
embryonic growth in postimplantation rat embryos.  Develop-
ment 1987, 100(3):431-439.
4. Siedner S, Kruger M, Schroeter M, Metzler D, Roell W, Fleischmann
BK, Helscheler J, Pfitzer G, Stehle R: Developmental changes in
contractility and sarcoplasmic proteins from early embry-
onic to the adult stage in the mouse heart.  J Physiol 2003,
548(2):493-505.
5. Guarner V, Contreras K, Carbo R: Effect of glucose and fatty acid
availability on neonatal and adult heart contractility.  Biol
Neonate 2002, 82(1):39-45.
6. Iyer NV, Kotch LE, Agani F, Leung SW, Laughner E, Wenger RH, Gas-
smann M, Gearhart JD, Lawler AM, Yu AY, Semenza GL: Cellular
and developmental control of oxygen homeostasis by
hypoxia-inducible factor 1α.  Genes Dev 1998, 12(2):149-162.
7. Barker DJ, Hanson MA: Altered regional blood flow in the fetus:
the origins of cardiovascular disease.  Acta Paediat 2004,
93(12):1635-1639.
8. Chaoui R: Coronary arteries in fetal life: physiology, malfor-
mations and the 'heart-sparing effect'.  Acta Paediatr Suppl 2004,
93(446):6-12.
9. Lewis AM, Mathieu-Costello O, McMillan PJ, Gilbert RD: Effect of
long-term, high-altitude hypoxia on the capillarity of the
ovine fetal heart.  Am J Physiol 1999, 277(2 Pt 2):H756-H762.
10. Broberg CS, Giraud GD, Schultz JM, Thornburg KL, Hohimer R, Davis
LE: Fetal anemia leads to augmented contractile response to
hypoxic stress in adulthood.  Am J Physiol Regul Integr Comp Physiol
2000, 279(5):R1813-R1820.
11. Davis LE, Hohimer AR, Morton MJ: Myocardial blood flow and
coronary conductance in chronically anemic fetal lambs.  Am
J Physiol 277(1 Pt 2):R306-R313.
12. Li G, Xiao Y, Estrella JL, Ducsay CA, Gilbert RD, Zhang L: Effect of
fetal hypoxia on heart susceptibility to ischemia and reper-
fusion injury in adult rat.  J Soc Gynecol Invest 2003, 10(5):265-274.
13. Xu Y, Williams SJ, O'Brien D, Davidge ST: Hypoxia or nutrient
restriction during pregnancy in rats leads to progressive car-
diac remodelling and impairs postischemic recovery in adult
male offspring.  FASEB J 2006, 20(8):1251-1253.
14. Felaco M, Grilli A, Gorbunov N, Di Napoli P, De Lutiis MA, Giulio C,
Taccardi AA, Barsotti A, Barbacane RC, Reale M, Conti P: Endothe-
lial NOS expression and ischemia-reperfusion in isolated
working rat hearts from hypoxic and hyperoxic conditions.
Biochimica et Biophysica Acta 2000, 1524(2–3):203-211.
15. Thompson LP, Aguan K, Pinkas G, Weiner CP: Chronic hypoxia
increases the NO contributrion of acetylcholine vasodilation
of the fetal guinea pig heart.  Am J Physiol 2000,
279(5):R1813-R1820.
16. Dong Y, Thompson LP: Differential expression of endothelial
nitric oxide synthase in coronary and cardiac tissue in
hypoxic fetal guinea pig hearts.  J Soc Gynecol Investig 2006,
13(7):483-490.
17. Fujita S, Roerig DL, Bosnjak ZL, Stowe DF: Effects of vasodilators
and perfusion pressure on coronary flow and simultaneous
release of nitric oxide from guinea pig hearts.  Cardiovasc Res
1998, 38(3):655-667.
18. Kingsbury MP, Robinson H, Flores NA, Sheridan DJ: Investigation
of mechanisms that mediate reactive hyperaemia in guinea
pig hearts: role of KATP channels, adenosine, nitric oxide and
prostaglandins.  Br J Pharmacol 2001, 132(6):1209-1216.
19. Heintz A, Koch T, Deussen A: Intact nitric oxide production is
obligatory for the sustained flow response during hypercap-
nic acidosis in guinea pig heart.  Cardiovasc Res 2005,
66(1):55-63.
20. Song D, O'Regan MH, Phillis JW: Role of nitric oxide in rat coro-
nary flow regulation during respiratory and metabolic acido-
sis.  Gen Pharmacol 1999, 32(5):571-575.
21. Phillis JW, Song D, O'Regan MH: Mechanisms involved in coro-
nary artery dilatation during respiratory acidosis in the iso-
lated perfused rat heart.  Basic Res Cardiol 2000, 95(2):93-97.
22. Chen Y, Torry RJ, Baumbach GL, Tomanek RJ: Proportional arte-
riolar growth accompanies cardiac hypertrophy induced by
volume overload.  Am J Physiol 1994, 267(6 Pt 2):H2132-H2137.
23. Coney AM, Marshall JM: Contribution of alpha2-adrenoceptors
and Y1 neuropeptide Y receptors to the blunting of sympa-
thetic vasoconstriction induced by systemic hypoxia in the
rat.  J Physiol 2007, 582(Pt3):1349-1359.
24. Cheng YZ, Hauton D: Cold acclimation induces physiological
cardiac hypertrophy and increases assimilation of triacylg-
lycerol metabolism through lipoprotein lipase.  Biochim Biophys
Acta 2008, 1781(10):618-626.BMC Cardiovascular Disorders 2009, 9:1 http://www.biomedcentral.com/1471-2261/9/1
Page 14 of 14
(page number not for citation purposes)
25. Ziada AM, Hudlicka O, Tyler KR, Wright AJ: Effect of long term
vasodilation on capillary growth and performance in rabbit
heart and skeletal muscle.  Cardiovasc Res 1984, 18(12):724-732.
26. Batra S, Rakusan K: Capillarization of the hypertrophic heart:
discrepancy of the results obtained by the triangulation and
domain methods.  J Cardiovasc Pharmacol 1991, 17(supplement
2):S151-S153.
27. Loose DS, Do YS, Chen TL, Feldman D: Demonstration of gluco-
corticoid receptors in the adrenal cortex: evidence for a
direct dexamethasone suppressive effect on rat adrenal
gland.  Endocrinology 1980, 107(1):137-146.
28. Myers DA, Hanson K, Mlynarczyk M, Kaushal KM, Ducsay CA: Long-
term hypoxia modulates expression of key genes regulating
adipose function in late-gestation ovine fetus.  Am J Physiol Regul
Integr Comp Physiol 2008, 294(4):R1312-R1318.
29. Fletcher PJ, Pfeffer JM, Pfeffer MA, Braunwald E: Left ventricular
diastolic pressure-volume relations in rat with healed myo-
cardial infarction. Effects on systolic function.  Circ Res 1981,
49(3):618-626.
30. He H, Giordano FJ, Hilal-Dandan R, Choi DJ, Rockman HA,
McDonough PM, Bluhm WF, Meyer M, Sayen MR, Swanson E, Dillman
WH:  Overexpression of rat sarcoplasmic reticulum Ca2+
ATPase gene in the heart of transgenic mice accelerates cal-
cium transients and cardiac relaxation.  J Clin Invest 1997,
100(2):380-389.
31. Baker DL, Hashimoto K, Grupp IL, Ji Y, Reed T, Loukianov E, Grupp
G, Bhagwhat A, Hoit B, Walsh R, Marban E, Periasamy M: Targeted
overexpression of the sarcoplasmic reticulum Ca2+ ATPase
increases cardiac contractility in transgenic mouse hearts.
Circ Res 1998, 83(12):1205-1214.
32. Greene AL, Lalli MJ, Ji Y, Babu GJ, Grupp I, Sussman M, Periasamy A:
Overexpression of SERCA2b in the heart leads to an
increase in sarcoplasmic reticulum calcium transport func-
tion and increased cardiac contractility.  J Biol Chem 2000,
275(32):24722-24727.
33. Paulus WJ, Shah AM: NO and cardiac diastolic function.  Cardio-
vasc Res 1999, 43:595-606.
34. Shah AM, Prendergast BD, Grocott-Mason R, Lewis MJ, Paulus WJ:
The influence of endothelium-derived nitric oxide on myo-
cardial contractile function.  Int J Cardiol 1995, 50:225-231.
35. Grocott-Mason R, Anning P, Evans H, Lewis MJ, Shah AM: Modula-
tion of left ventricular relaxation in isolated ejecting heart by
endogenous nitric oxide.  Am J Physiol 1994, 267(5 Pt
2):H1804-H1813.
36. Kayar SR, Weiss HR: Capillary recruitment and heterogeneity
of perfused capillary distribution in dog myocardium.  Micro-
circ Endothelium Lymphatics 1991, 7(1-3):77-108.
37. Murashita T, Kempsford RD, Hearse DJ: Oxygen supply and oxy-
gen demand in the isolated working rabbit heart perfused
with a sanguineous crystalloid solution.  Cardiovasc Res 1991,
25(3):198-206.
38. Schenkman KA, Beard DA, Ciesielski WA, Fiegl EO: Comparison of
buffer and red blood cell perfusion of guinea pig heart oxy-
genation.  Am J Physiol Heart Circ Physiol 2003, 285(5):H1819-1825.
39. Tsagalou EP, Anastasiou-Nana M, Agapitos E, Gika A, Drakos SG,
Terrovitis JV, Ntalianis A, Nanas JN: Depressed coronary flow
reserve is associated with decreased myocardial capillary
density in patients with heart failure due to idiopathic dilated
cardiomyopathy.  J Am Coll Cardiol 2008, 52(17):1391-1398.
40. Knaapen P, Germans T, Camici PG, Rimoldi OE, ten Cate FJ, ten Berg
JM, Dijkmans PA, Boellaard R, van Dockum WG, Gotte MJ, Twisk JW,
van Rossum AC, Lammertsma AA, visser FC: Determinants of cor-
onary microvascular dysfunction in sympatomatic hyper-
trophic cardiomyopathy.  Am J Physiol Heart Circ Physiol 2008,
294(2):H986-H993.
41. Kuo L, Davis MJ, Chilian WM: Endothelium-dependent, flow-
induced dilation of isolated coronary arterioles.  Am J Physiol
1990, 259:H1063-H1070.
42. Baker JE, Holman P, Kalyanaraman B, Griffith OW, Pritchard KA Jr:
Adaptation to chronic hypoxia confers tolerance to subse-
quent myocardial ischemia by increased nitric oxide produc-
tion.  Ann NY Acad Sci 1999, 874:236-253.
43. Balligand JL, Kobzik L, Han X, Kaye DM, Belhassen L, O'Hara DS,
Kelly RA, Smith TW, Michel T: Nitric oxide-parasympathetic sig-
nalling is due to activation of constitutive endothelial (Type
III) nitric oxide synthase in cardiac myocytes.  J Biol Chem 1995,
270(24):14582-14586.
44. Luss H, Watkins SC, Freeswick PD, Imro AK, Nussler AK, Billiar TR,
Simmons RL, del Nido PJ, McGowan FZ Jr: Characterisation of
inducible nitric oxide synthase expression in endotoxemic
rat cardiomyocytes in vivo and following cytokine exposure
in vitro.  J Mol Cell Cardiol 1995, 27(9):2015-2029.
45. Wildhirt SM, Weismueller S, Schulze C, Conrad N, Kornberg A, Rei-
chart B: Inducible nitric oxide synthase activation after
ischemia/reperfusion contributes to myocardial dysfunction
and extent of infarct size in rabbits: evidence for a late phase
of nitric oxide-mediated reperfusion injury.  Cardiovasc Res
1993, 43(3):698-711.
46. Haywood GA, Tsao PS, Leyen HE Von der, Mann MJ, Keeling PJ, Trin-
dade PT, Lewis NP, Bryne CD, Rickenbacher PR, Bishopric NH,
Cooke JP, McKenna WJ, Fowler MB: Expression of inducible
nitric oxide synthase in human heart failure.  Circulation 1996,
93(6):1087-1094.
47. Talukder MA, Fujiki T, Morikawa K, Motoishi M, Kubota H, Morishita
T, Tsutsui M, Takeshita A, Shimokawa H: Up-regulated neuronal
nitric oxide synthase compensates coronary flow response
to bradykinin in endothelial nitric oxide synthase-deficient
mice.  J Cardiovasc Pharmacol 2004, 44(4):437-445.
48. Huang A, Sun D, Shesely EG, Levee EM, Koller A, Kaley G: Neuronal
NOS-dependent dilation to flow in coronary arteries of male
eNOS-KO mice.  Am J Physiol Heart Circ Physiol 2002,
282(2):H429-H436.
49. Muhlfeld C, Singer D, Englehardt N, Richter J, Schmiedl A: Electron
microscopy and microcalorimetry of the postnatal rat heart
(Rattus norvegicus).  Comp Biochem Physiol Part A 2005,
141(3):310-318.
50. Hemmings DG, Williams SJ, Davidge ST: Increased myogenic tone
in 7-month-old adult male but not female offspring from rat
dams exposed to hypoxia during pregnancy.  Am J Physiol 2005,
289(7):H674-H682.
51. Mattfeldt T, Mall G: Growth of capillaries and myocardial cells
in the normal rat heart.  J Mol Cell Cardiol 1987,
19(12):1237-1244.
52. Engelmann GL, Vitullo JC, Gerrity RG: Morphometric analysis of
cardiac hypertrophy during development, maturation and
senescence in spontaneously hypertensive rats.  Circ Res 1987,
60(4):487-494.
53. Bae S, Xiao Y, Li G, Casiano CA, Zhang L: Effect of maternal
hypoxic exposure during gestation on apoptosis in fetal rat
heart.  Am J Physiol Heart Circ Physiol 2003, 285(3):H983-H990.
54. Morrison JL, Botting KJ, Dyer JL, Williams SJ, Thornburg KL, McMillen
IC:  Restriction of placental function alters heart develop-
ment in the sheep fetus.  Am J Physiol Regul Integr Comp Physiol
2007, 293(1):R306-R313.
55. Corstius HB, Zimanyi MA, Maka N, Herath T, Thomas W, Laarse A
van der, Wreford NG, Black MJ: Effect of intrauterine growth
restriction on the number of cardiomyocytes in rat hearts.
Pediatric Res 2005, 57(6):796-800.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2261/9/1/prepub